Filter Results
:
(88)
Show Results For
- All HBS Web (328)
- Faculty Publications (75)
Show Results For
- All HBS Web (328)
- Faculty Publications (75)
Sort by
- 01 Sep 2018
- News
Your Keyboard Is Listening
want to know if I have one of these diseases?’” “Researchers think there are subtle signs that precede the known symptoms of diseases like Huntington’s and Alzheimer’s,” explains Robi Blumenstein (MBA 1984), president of the CHDI...
View Details
Keywords:
April White
- 01 Sep 2004
- News
A Market-Based Prescription
system because there will be fewer obstacles standing in the way of physician innovations, and because — if markets follow money, which we teach in business school — the successful management of chronic View Details
- 24 Apr 2014
- News
Optimizing search technology
Olivier Dumon (MBA 1998) is managing director of academic and government markets for global publishing giant Elsevier, where he’s working on optimizing online search protocols. He believes that the more the technology is improved, the...
View Details
- 01 Dec 2013
- News
To Market, to Market
BLAVATNIK Photo courtesy of Blavatnik Family Foundation Universities are ripe with new advances in science and technology, and Harvard is no exception. But developing those findings into breakthrough therapies and cures for disease is a...
View Details
- 20 Aug 2014
- News
With No Time to Lose
into ALS research, and removed some critical barriers to the development of treatments. “Our focus, from the start, was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed with the disease in 2004, just weeks...
View Details
Keywords:
Margie Kelley
- 26 Jan 2021
- News
Clubs See Wealth in FemTech; Health Care Alumni Look at COVID Response
health care, inequities in female-specific disease areas, and the role of FemTech startups in disrupting women's health care and empowering women. Linda Greub (MBA 1987) Stasia Obremskey (MBA 1987) Alice Zheng (MBA 2014) Linda Greub (MBA...
View Details
Keywords:
Margie Kelley
- 03 Mar 2017
- News
Big Blue’s Big Bet
secondary leukemia caused by myelodysplastic syndrome, a group of diseases in which the bone marrow makes few healthy blood cells. The doctors changed the woman’s therapy plan, and her health improved considerably. She was discharged from...
View Details
Keywords:
Paul Kix; illustrations by Dan Page
- 01 Dec 2008
- News
Business at the Summit
those diseases. “These people have no voice in the marketplace,” Gates said. As a result, ten times as much funding is devoted to research on the prevention of male baldness as malaria, a disease that kills more than 1 million people each...
View Details
- 01 Oct 2021
- News
New Biotech Joint Degree Program Kicks Off
Frontiers in Therapeutics is an ethics and management course on the world’s most pressing unsolved medical challenges. The impetus for the program came from recognizing that the biotech sector needs strong, ethical leaders who can break...
View Details
- 01 Dec 2005
- News
Pedal Mettle
player who was diagnosed with Hodgkin’s disease in 1995, Berté saw the cancer return six months after she completed her initial treatment. She then enrolled in a clinical trial including chemotherapy, radiation, and a stem-cell...
View Details
- 01 Feb 1997
- News
Herzlinger on Health Care: Revolution in Evolution
result. Now, if that same equipment were used in a focused factory, only equipment relevant to that disease would be purchased, and it would be used efficiently. But should health care be market-driven, particularly when one result is...
View Details
- 01 Jun 2024
- News
Conducting Business
in 1969. Ginny’s eyes teared up. “He was our father,” she said, and explained that he had developed Alzheimer’s disease in his 50s and died in 1996. Dick Vancil played an enormous role in my life. He was a master of the case method, as...
View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
market and exit opportunity? Or should NextGen Jane choose the tool most likely to be adopted by ob-gyns to manage their patient populations? The Answers: The idealistic answer is to focus on the gynecological View Details
Keywords:
Jen McFarland Flint
- 01 Jun 2018
- News
Floor It
and people.” Hamermesh notes that only one or two disease foundations currently have a venture philanthropy fund. In addition, more and more private-sector companies are focusing their efforts on a single disease. “Those are both areas of...
View Details
Keywords:
Julia Hanna; illustration by Mengxin Li
- 01 Dec 2004
- News
The Future of Stem Cells
cardiovascular disease. In addition, apart from any possible therapeutic benefits, embryonic stem-cell research could play a central role in helping to understand the nature and development of disease generally. Spar, the Spangler Family...
View Details
Keywords:
Garry Emmons
- 21 May 2019
- News
Confronting the Future of Climate Change in the Midwest
New weather patterns brought on by climate change will require updated farming practices, effective water management, and innovative pest and disease management in the Midwest and around the globe....
View Details
Keywords:
Agriculture
- 01 Sep 2010
- News
Start-Ups "R" Us
which enables Web sites to protect themselves from online attacks; Diagnostics For All, a nonprofit that develops low-cost disease diagnostics for the developing world; and Finale, a Boston-area chain of upscale restaurants specializing...
View Details
- 01 Jun 2007
- News
Mission Possible
services organization cofounded by Tierney and Jeff Bradach, then a member of the HBS faculty and now Bridgespan’s managing partner. The organization works to boost the performance of nonprofits and foundations, thereby improving their...
View Details
- 04 Sep 2019
- News
Accelerating Scientific Discovery
will also strengthen collaboration by helping managers and scientists understand each other’s perspectives—especially regarding language, goals, expectations, and timelines—so that they can reconcile the needs of commerce and science....
View Details
Keywords:
Jennifer Gillespie
- 01 Sep 2008
- News
Mara Aspinall
1,500-person division is a leader in the emerging field of personalized medicine, which treats cancer and other diseases with customized therapies that take into account the patient’s specific genetic traits. With HBS professor Richard...
View Details